Welcome, everyone, and thank you for joining the Daré Bioscience Virtual Bus Tour. My name is Jenene Thomas. I am CEO of JTC IR, and I will be the moderator for today's event. So today, the company is ...

Greetings, and welcome to Gentherm's Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I'll now turn the conference over to ...

Embedding a patient-focused approach across all health care settings could help better address the problem of missingness in ...

Not all therapy is designed to work the same way. This expert-backed guide breaks down CBT, DBT, EMDR, ACT and more—so you can find the approach that best fits what you’re facing.

Focused Energy recently raised an oversubscribed $240 million Series A round, one of the largest early-stage rounds for a fusion power startup. The new round, announced last week, brings the company’s ...

DARMSTADT, Germany--(BUSINESS WIRE)--Focused Energy, the world’s leading laser fusion company, has raised $240 million in a Series A financing round, making it the largest fully secured Series A ...

Last week, OpenAI shocked the mathematical community by revealing that one of its internal artificial intelligence (AI) models had found a counterexample to a famous conjecture made by legendary ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

In 2021, dermatologist David Ozog was on holiday with his family in the Bahamas, when his 18-year-old son had a massive stroke. The teenager was airlifted to Florida, and then to Chicago for surgery.

Recent decades have witnessed exponential growth in the volume and methodological rigor of addiction-related research studies (1). The depth of this new knowledge has occurred in areas of addiction ...

Solution-Focused Brief Therapy (SFBT) is a short-term, goal-directed therapeutic approach widely used across diverse settings. While prior evidence supports its overall effectiveness, the empirical ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game changer. The FDA no longer agrees that data ...